Identität

Valgancyclovir

Nicht angegeben · C14H22N6O5

01Identität

Lazychem IDLC-34967
CAS RNNicht angegeben
PubChem CID135398519
Molecular formulaC14H22N6O5
Molecular weight354.36 g/mol
IUPAC name[2-[(2-amino-6-oxo-1H-purin-9-yl)methoxy]-3-hydroxypropyl] 2-amino-3-methylbutanoate
InChIKeyWPVFJKSGQUFQAP-UHFFFAOYSA-N

02Struktur und Stereochemie

2D structurePubChem CID 135398519
Two-dimensional chemical structure of Valgancyclovir
Two-dimensional structure for the PubChem identity linked to this record. Confirm the identifiers before analytical use.

The parsed structure contains 2 rings, includes aromatic atoms, includes aliphatic carbon. These statements are calculated from the published structure string.

Defined stereocentres0
Ring count2
Secondary amines0
Tertiary amines0
SMILESCC(C)C(C(=O)OCC(CO)OCN1C=NC2=C1N=C(NC2=O)N)N
InChINicht angegeben

03Stereochemistry

The published structure contains 0 defined and 2 unassigned tetrahedral stereocentres. The exact wedge and dash depiction is shown above.

Defined centres0Structure assigned
Unassigned centres2Structure unspecified
Assignment statusUnassignedExact published identity
Tetrahedral upper bound≤ 4Before symmetry reduction

Published same-connectivity configurations

3 records

These records have the same connectivity, molecular formula and protonation layer, but a different complete InChIKey stereochemical layer. Only separately structure-linked records are shown.

Scope: The mathematical 2^n value is only an upper bound. Symmetry and other stereogenic elements can change the number of distinct stereoisomers. A hypothetical configuration is not published as a compound record without a verified structure identity.

04Status in Indien

Exact-compound status is evaluated only against the published name and CAS number. Confirm the current official instrument before a regulatory decision.

05Namen und Beziehungen

API und Ausgangsarzneistoff

Nicht angegeben

Namen und Beziehungen

    Verunreinigungen und verwandte Verbindungen

      06Quellen